The Opioid Crisis: The War on Drugs Is Over. Long Live the War on Drugs

Author:

Gottschalk Marie1

Affiliation:

1. Department of Political Science, University of Pennsylvania, Philadelphia, Pennsylvania, USA;

Abstract

A closer examination of media coverage, the response of law enforcement and policy makers, the legislative record, and the availability of proven, high-quality treatments for substance abuse casts doubt on claims that the country pivoted toward public health and harm-reduction strategies to address the opioid crisis because its victims were disproportionately white people. Law enforcement solutions directed at people who use and sell street drugs continue to far outpace public health and harm-reduction strategies. Government support for expanding access to proven treatments for opioid use disorder that save and rebuild lives remains paltry given the scale of this public health catastrophe. And although the rhetoric has been somewhat more sympathetic, at times it rivals the excesses of the crack era. The article examines the various phases of the opioid crisis as they have unfolded over the past 25 years; related geographic and racial shifts in overdose fatalities with each new phase; media coverage of the crisis; the federal government's response, including by the US Congress and presidents from George H.W. Bush to Joe Biden; punitive developments at the state and local levels; and the country's poor record on prevention and making effective treatment widely available for people with substance use disorder.

Publisher

Annual Reviews

Subject

Law

Reference232 articles.

1. Abrahamson D. 2016. Legal experts urge UN to reject drug courts. Drug Policy Alliance, April 6. https://www.drugpolicy.org/blog/legal-experts-urge-un-reject-drug-courts

2. The Opioid Fix

3. Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder

4. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff

Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3